Filing Flows › Pediatrix Medical Group (MD) › Guidance history
Pediatrix Medical Group (MD) guidance history: what it guided and what it reported
Pediatrix Medical Group gave guidance in 3 earnings releases on file since Jul 15, 2026. Its releases raised guidance once and lowered it 0 times.
Adjusted EBITDA
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $280M–$300M (Jul 15, 2026) → reaffirmed $280M–$300M (Aug 4, 2026) → raised $290M–$300M (Oct 29, 2026) | — | to be reported | — |
The latest quarter
Pediatrix Medical Group, Q3 2026: revenue $501M (+2% year over year), operating margin 13.0%, net earnings $47.0M, operating cash flow $117M. The chart follows the revenue to costs, profit and cash.
Questions
Does Pediatrix Medical Group beat its guidance?
Pediatrix Medical Group gave guidance in 3 earnings releases on file since Jul 15, 2026. Its releases raised guidance once and lowered it 0 times.
How often does Pediatrix Medical Group raise guidance?
Its earnings releases raised guidance once and lowered it 0 times since Jul 15, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.